US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist
  • 14.030
  • +0.230+1.67%
Close Dec 13 16:00 ET
361.66MMarket Cap-12.49P/E (TTM)

Contineum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
50M
0
0
50M
0
0
0
Operating revenue
--0
--0
--0
--50M
--0
--0
--50M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
60.79%12.97M
-1.08%10.94M
94.13%9.93M
49.31%33.92M
77.57%9.68M
8.07M
11.06M
5.12M
-20.69%22.72M
5.45M
Selling and administrative expenses
106.75%3.25M
89.83%3.04M
45.11%2.15M
8.48%6.32M
11.30%1.66M
--1.57M
--1.6M
--1.48M
-7.33%5.83M
--1.5M
-General and administrative expense
106.75%3.25M
89.83%3.04M
45.11%2.15M
8.48%6.32M
11.30%1.66M
--1.57M
--1.6M
--1.48M
-7.33%5.83M
--1.5M
Research and development costs
49.68%9.73M
-16.48%7.9M
114.15%7.78M
63.39%27.6M
102.63%8.01M
--6.5M
--9.46M
--3.63M
-24.45%16.89M
--3.95M
Operating profit
-60.79%-12.97M
-128.11%-10.94M
-94.13%-9.93M
170.76%16.08M
-77.57%-9.68M
-8.07M
38.94M
-5.12M
20.69%-22.72M
-5.45M
Net non-operating interest income expense
57.89%2.74M
255.42%2M
429.45%1.64M
1,079.09%4.4M
642.74%1.79M
1.74M
563K
309K
246.27%373K
241K
Non-operating interest income
57.89%2.74M
194.70%2M
307.98%1.64M
505.26%4.61M
423.39%1.79M
--1.74M
--679K
--401K
888.31%761K
--342K
Non-operating interest expense
--0
--0
--0
-46.39%208K
--0
--0
--116K
--92K
16.87%388K
--101K
Other net income (expense)
5.56%-34K
-102.36%-66K
-583.33%-123K
241.40%2.7M
98.09%-44K
-36K
2.79M
-18K
-1,825.25%-1.91M
-2.3M
Gain on sale of security
----
450.00%11K
---117K
66.67%5K
200.00%3K
----
--2K
----
50.00%3K
---3K
Special income (charges)
--0
--0
----
257.79%2.87M
--0
--0
--2.87M
----
-18,070.00%-1.82M
---2.29M
-Less:Other special charges
----
----
----
-257.79%-2.87M
--0
----
---2.87M
----
18,070.00%1.82M
--2.29M
Other non- operating income (expenses)
5.56%-34K
-1.32%-77K
66.67%-6K
-92.39%-177K
-370.00%-47K
---36K
---76K
---18K
-1.10%-92K
---10K
Income before tax
-61.20%-10.27M
-121.30%-9.01M
-74.48%-8.42M
195.53%23.17M
-5.56%-7.93M
-6.37M
42.29M
-4.82M
16.37%-24.25M
-7.51M
Income tax
0
0
0
450K
-161K
-118K
729K
0
0
0
Net income
-64.25%-10.27M
-121.68%-9.01M
-74.48%-8.42M
193.68%22.72M
-3.42%-7.77M
-6.25M
41.56M
-4.82M
16.37%-24.25M
-7.51M
Net income continuous Operations
-64.25%-10.27M
-121.68%-9.01M
-74.48%-8.42M
193.68%22.72M
-3.42%-7.77M
---6.25M
--41.56M
---4.82M
16.37%-24.25M
---7.51M
Minority interest income
Net income attributable to the parent company
-64.25%-10.27M
-121.68%-9.01M
-74.48%-8.42M
193.68%22.72M
-3.42%-7.77M
-6.25M
41.56M
-4.82M
16.37%-24.25M
-7.51M
Preferred stock dividends
Other preferred stock dividends
0
0
0
35.7M
Net income attributable to common stockholders
-64.25%-10.27M
-253.50%-9.01M
-74.48%-8.42M
193.68%22.72M
344.68%18.38M
-6.25M
5.87M
-4.82M
16.37%-24.25M
-7.51M
Basic earnings per share
-73.13%-0.4
-210.80%-0.39
-7.53%-0.3111
193.50%1.36
250.79%0.6793
-0.231
0.352
-0.2893
16.37%-1.4545
-0.4505
Diluted earnings per share
-73.13%-0.4
-334.88%-0.39
-7.53%-0.3111
177.00%1.12
250.79%0.6793
-0.231
0.166
-0.2893
16.37%-1.4545
-0.4505
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 00050M0050M000
Operating revenue --0--0--0--50M--0--0--50M--0--0--0
Cost of revenue
Gross profit
Operating expense 60.79%12.97M-1.08%10.94M94.13%9.93M49.31%33.92M77.57%9.68M8.07M11.06M5.12M-20.69%22.72M5.45M
Selling and administrative expenses 106.75%3.25M89.83%3.04M45.11%2.15M8.48%6.32M11.30%1.66M--1.57M--1.6M--1.48M-7.33%5.83M--1.5M
-General and administrative expense 106.75%3.25M89.83%3.04M45.11%2.15M8.48%6.32M11.30%1.66M--1.57M--1.6M--1.48M-7.33%5.83M--1.5M
Research and development costs 49.68%9.73M-16.48%7.9M114.15%7.78M63.39%27.6M102.63%8.01M--6.5M--9.46M--3.63M-24.45%16.89M--3.95M
Operating profit -60.79%-12.97M-128.11%-10.94M-94.13%-9.93M170.76%16.08M-77.57%-9.68M-8.07M38.94M-5.12M20.69%-22.72M-5.45M
Net non-operating interest income expense 57.89%2.74M255.42%2M429.45%1.64M1,079.09%4.4M642.74%1.79M1.74M563K309K246.27%373K241K
Non-operating interest income 57.89%2.74M194.70%2M307.98%1.64M505.26%4.61M423.39%1.79M--1.74M--679K--401K888.31%761K--342K
Non-operating interest expense --0--0--0-46.39%208K--0--0--116K--92K16.87%388K--101K
Other net income (expense) 5.56%-34K-102.36%-66K-583.33%-123K241.40%2.7M98.09%-44K-36K2.79M-18K-1,825.25%-1.91M-2.3M
Gain on sale of security ----450.00%11K---117K66.67%5K200.00%3K------2K----50.00%3K---3K
Special income (charges) --0--0----257.79%2.87M--0--0--2.87M-----18,070.00%-1.82M---2.29M
-Less:Other special charges -------------257.79%-2.87M--0-------2.87M----18,070.00%1.82M--2.29M
Other non- operating income (expenses) 5.56%-34K-1.32%-77K66.67%-6K-92.39%-177K-370.00%-47K---36K---76K---18K-1.10%-92K---10K
Income before tax -61.20%-10.27M-121.30%-9.01M-74.48%-8.42M195.53%23.17M-5.56%-7.93M-6.37M42.29M-4.82M16.37%-24.25M-7.51M
Income tax 000450K-161K-118K729K000
Net income -64.25%-10.27M-121.68%-9.01M-74.48%-8.42M193.68%22.72M-3.42%-7.77M-6.25M41.56M-4.82M16.37%-24.25M-7.51M
Net income continuous Operations -64.25%-10.27M-121.68%-9.01M-74.48%-8.42M193.68%22.72M-3.42%-7.77M---6.25M--41.56M---4.82M16.37%-24.25M---7.51M
Minority interest income
Net income attributable to the parent company -64.25%-10.27M-121.68%-9.01M-74.48%-8.42M193.68%22.72M-3.42%-7.77M-6.25M41.56M-4.82M16.37%-24.25M-7.51M
Preferred stock dividends
Other preferred stock dividends 00035.7M
Net income attributable to common stockholders -64.25%-10.27M-253.50%-9.01M-74.48%-8.42M193.68%22.72M344.68%18.38M-6.25M5.87M-4.82M16.37%-24.25M-7.51M
Basic earnings per share -73.13%-0.4-210.80%-0.39-7.53%-0.3111193.50%1.36250.79%0.6793-0.2310.352-0.289316.37%-1.4545-0.4505
Diluted earnings per share -73.13%-0.4-334.88%-0.39-7.53%-0.3111177.00%1.12250.79%0.6793-0.2310.166-0.289316.37%-1.4545-0.4505
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List